> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Additional FDA Drug Compounding Research
- URL: https://www.fdaweb.com/additional-fda-drug-compounding-research/
- Published: 2018-09-27T12:00:00.000Z
- Updated: 2026-09-15T00:34:44.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5142457

FDA says the National Academies of Science, Engineering & Medicine (NASEM) will conduct research to help inform the public and agency policies regarding compounded drugs. An agency [statement](https://www.fda.gov/Drugs/DrugSafety/ucm621776.htm?ref=fdaweb.com) also says FDA has expanded its agreements with the University of Maryland and Johns Hopkins University Centers for Regulatory Science and Innovation for additional compounded drug research studies. The document describes the two studies NASEM will conduct and the expanded projects with the University of Maryland/Johns Hopkins consortium.

“FDA believes the results of these research projects will provide important information that will inform the agency’s policies and increase public understanding regarding these compounded products,” the statement concludes.